Consumption Status of Caffeine and Adverse Effects Experience Among Anesthetists
Sponsor
Ain Shams University (Other)
Overall Status
Completed
CT.gov ID
NCT05323578
Collaborator
(none)
168
1
2.9
58.1
Study Details
Study Description
Brief Summary
High-caffeine consumption has been increasing in physicians, frequently causing the most common symptoms such as tremor, insomnia, anxiety, and nervousness and rarely leading to serious adverse effects like seizure, acute mania, and stroke due to caffeine overdose. There have been no studies regarding analysis of high-caffeine consumption and its adverse effects among anesthetists.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
This study was to examine high-caffeine consumption patterns, associated factors, and adverse effects based on responses anesthetists with different age of experience.
Study Design
Study Type:
Observational
Actual Enrollment
:
168 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Consumption Status of Caffeine and Adverse Effects Experience Among Anesthetists
Actual Study Start Date
:
Apr 18, 2022
Actual Primary Completion Date
:
Jun 30, 2022
Actual Study Completion Date
:
Jul 15, 2022
Outcome Measures
Primary Outcome Measures
- Prevalence of safe and unsafe caffeine consumption [24 hours]
Average daily amount of caffeine consumption in mg
Eligibility Criteria
Criteria
Ages Eligible for Study:
24 Years
to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Any anesthetist
Exclusion Criteria:
- Pregnancy
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Ain Shams University Hospitals | Cairo | Egypt |
Sponsors and Collaborators
- Ain Shams University
Investigators
- Principal Investigator: Raham H Mostafa, MD, Ain Shams University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Raham Hasan Mostafa, MD,
Assistant Professor of Anesthesia,
Ain Shams University
ClinicalTrials.gov Identifier:
NCT05323578
Other Study ID Numbers:
- R 66/2022
First Posted:
Apr 12, 2022
Last Update Posted:
Aug 15, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No